Skip to main content

Kodiak Sciences Inc.

For the period ended Mar 31, 2026. Filed May 7, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2026 · Filed May 7, 2026

KOD$108.06+0.9%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Consolidated Balance Sheets

Condensed Consolidated Balance Sheets (unaudited)

(in thousands, except share and per share amounts)

March 31,2026December 31,2025
Assets
Current assets:
Cash and cash equivalents$169,530$209,862
Prepaid expenses and other current assets5,7284,954
Total current assets175,258214,816
Restricted cash6,1846,184
Property and equipment, net81,51285,258
Operating lease right-of-use asset34,37536,606
Other assets8,6778,669
Total assets$306,006$351,533
Liabilities and stockholders’ equity
Current liabilities:
Accounts payable$11,344$12,863
Accrued and other current liabilities26,56920,607
Operating lease liability11,66012,063
Total current liabilities49,57345,533
Long-term operating lease liability44,33247,117
Liability related to sale of future royalties100,000100,000
Long-term deposit—1,500
Total liabilities193,905194,150
Commitments and contingencies (Note 5)
Stockholders’ equity:
Preferred stock, $0.0001 par value – 10,000,000 shares authorized;none issued——
Common stock, $0.0001 par value – 490,000,000 shares authorized; 62,155,685 and 61,758,454 shares issued and outstanding, respectively66
Additional paid-in capital1,728,9581,716,082
Accumulated deficit(1,616,863)(1,558,705)
Total stockholders’ equity112,101157,383
Total liabilities and stockholders’ equity$306,006$351,533
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.